Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate.
Butyrate and the other short-chain fatty acids (SCFAs) are the most abundant anions in the colonic lumen. Also, butyrate is the preferred energy source for colonocytes and has been shown to regulate colonic electrolyte and fluid absorption. Previous studies from our group have demonstrated that the HCO(3)(-)/SCFA(-) anion exchange process is one of the major mechanisms of butyrate transport across the purified human colonic apical membrane vesicles and the apical membrane of human colonic adenocarcinoma cell line Caco-2 and have suggested that it is mainly mediated via monocarboxylate transporter-1 (MCT-1) isoform. However, little is known regarding the regulation of SCFA transport by various hormones and signal transduction pathways. Therefore, the present studies were undertaken to examine whether hydrocortisone and phorbol 12-myristate 13-acetate (PMA) are involved in a possible regulation of the butyrate/anion exchange process in Caco-2 cells. The butyrate/anion exchange process was assessed by measuring a pH-driven [(14)C]butyrate uptake in Caco-2 cells. Our results demonstrated that 24-h incubation with PMA (1 microM) significantly increased [(14)C]butyrate uptake compared with incubation with 4alphaPMA (inactive form). In contrast, incubation with hydrocortisone had no significant effect on butyrate uptake in Caco-2 cells compared with vehicle (ethanol) alone. Induction of butyrate uptake by PMA appeared to be via an increase in the maximum velocity (V(max)) of the transport process with no significant changes in the K(m) of the transporter for butyrate. Parallel to the increase in the V(max) of [(14)C]butyrate uptake, the MCT-1 protein level was also increased in response to PMA incubation. Our studies demonstrated that the butyrate/anion exchange was increased in response to PMA treatment along with the induction in the level of MCT-1 expression in Caco-2 cells.
Alrefai
W A
WA
Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Tyagi
S
S
Gill
R
R
Saksena
S
S
Hadjiagapiou
C
C
Mansour
F
F
Ramaswamy
K
K
Dudeja
P K
PK
D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D020148:Butyric Acid / Q000493:pharmacokinetics*; D018938:Caco-2 Cells / Q000187:drug effects / Q000378:metabolism; D002273:Carcinogens / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000378:metabolism* / Q000473:pathology; D004334:Drug Administration Schedule; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D019344:Lactic Acid / Q000494:pharmacology; D027501:Monocarboxylic Acid Transporters / Q000378:metabolism / Q000502:physiology; D027981:Symporters / Q000378:metabolism / Q000502:physiology; D013755:Tetradecanoylphorbol Acetate / Q000008:administration & dosage / Q000494:pharmacology*; D000099233:Monocarboxylate Transport Protein 1
D020148:Butyric Acid; D002273:Carcinogens; D006854:Hydrocortisone; D019344:Lactic Acid; D027501:Monocarboxylic Acid Transporters; D027981:Symporters; D013755:Tetradecanoylphorbol Acetate; D000099233:Monocarboxylate Transport Protein 1